Search Within

Harry W Herr

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (44)
  2. Meeting Abstract (10)
  3. Correspondence (2)
  4. Conference Paper (1)
  5. Editorial (1)
  6. Review (1)
Groups
  1. Epidemiology and Biostatistics (59)
  2. Surgery (59)
  3. Urology (59)
  4. Population Sciences Research Program (35)
  5. Biostatistics Service (33)
  6. Health Outcomes Research Group (31)

More Groups

People
  1. Sherri Donat (39)
  2. Bernard Bochner (38)
  3. Guido Dalbagni (37)
  4. Dean Bajorin (18)
  5. Andrew Vickers (16)
  6. Irina Ostrovnaya (14)

More People

Years
  1. 2024 (2)
  2. 2023 (3)
  3. 2022 (8)
  4. 2021 (2)
  5. 2020 (2)
  6. 2019 (2)

More Years

Publications
  1. Journal of Urology (13)
  2. Journal of Clinical Oncology (12)
  3. European Urology (6)
  4. Urology (5)
  5. Urologic Oncology: Seminars and Original Investigations (3)
  6. BJU International (2)

More Publications

Publishers
  1. Elsevier Science, Inc. (24)
  2. American Society of Clinical Oncology (14)
  3. Elsevier Inc. (6)
  4. Wiley Blackwell (5)
  5. Oxford University Press (3)
  6. American Association for Cancer Research (2)

More Publishers

Results (59)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Age-adjusted charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer
    Journal Article

    Koppie, T. M.; Serio, A. M.; Vickers, A. J.; Vora, K.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Bochner, B. H.
    Cancer (2008)

    Fulltext@MSK | Save
  • Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer
    Journal Article

    Raj, G. V.; Herr, H.; Serio, A. M.; Donat, S. M.; Bochner, B. H.; Vickers, A. J.; Dalbagni, G.
    Journal of Urology (2007)

    Fulltext@MSK | Save
  • Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract
    Journal Article

    Galsky, M. D.; Iasonos, A.; Mironov, S.; Scattergood, J.; Donat, S. M.; Bochner, B. H.; Herr, H. W.; Russo, P.; Boyle, M. G.; Bajorin, D. F.
    Urology (2007)

    Fulltext@MSK | Save
  • Prospective trial of ifosfamide, paclitaxel, and cisplatin (ITP) in patients with advanced non-transitional cell (non-TCC) carcinomas of the urothelial tract
    Meeting Abstract

    Galsky, M. D.; Iasonos, A.; Mironov, S.; Scattergood, J.; Donat, S. M.; Bochner, B. H.; Herr, H. W.; Russo, P.; Boyle, M. G.; Bajorin, D. F.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Clinical characteristics of bladder cancer in patients previously treated with radiation for prostate cancer
    Journal Article

    Sandhu, J. S.; Vickers, A. J.; Bochner, B.; Donat, S. M.; Herr, H. W.; Dalbagni, G.
    BJU International (2006)

    Fulltext@MSK | Save
  • Significance of intraoperative ureteral evaluation at radical cystectomy for urothelial cancer
    Journal Article

    Raj, G. V.; Tal, R.; Vickers, A.; Bochner, B. H.; Serio, A.; Donat, S. M.; Herr, H.; Olgac, S.; Dalbagni, G.
    Cancer (2006)

    Fulltext@MSK | Save
  • Formulas calculating creatinine clearance are inadequate for determining eligibility for cisplatin-based chemotherapy in bladder cancer
    Journal Article

    Raj, G. V.; Iasonos, A.; Herr, H.; Donat, S. M.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Association between urinary cytology and pathology for nontransitional cell malignancies of the urinary tract
    Journal Article

    Raj, G. V.; Bochner, B. H.; Vickers, A.; Teper, E.; Lin, O.; Donat, S. M.; Herr, H.; Dalbagni, G.
    Journal of Urology (2006)

    Fulltext@MSK | Save
  • Natural history of positive urinary cytology after radical cystectomy
    Journal Article

    Raj, G. V.; Bochner, B. H.; Serio, A. M.; Vickers, A.; Donat, S. M.; Herr, H.; Lin, O.; Dalbagni, G.
    Journal of Urology (2006)

    Fulltext@MSK | Save
  • Assessing interactions between mdm-2, p53, and bcl-2 as prognostic variables in muscle-invasive bladder cancer treated with neo-adjuvant chemotherapy followed by locoregional surgical treatment
    Journal Article

    Maluf, F. C.; Cordon-Cardo, C.; Verbel, D. A.; Satagopan, J. M.; Boyle, M. G.; Herr, H.; Bajorin, D. F.
    Annals of Oncology (2006)

    Fulltext@MSK | Save